| Affiliation: | 1. LMC Diabetes and Endocrinology, Brampton, Ontario, Canada;2. Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel;3. Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts;4. Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada;5. Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas;6. Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK;7. BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden |
